Related Experiment Video
Updated: Jun 15, 2026

05:46
Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
[Premature rupture membrane at term with unfavourable cervix]
Chiraz El Fekih1, Nadia Ouerdiane, Chaouki Mrezguia
1Service de gynéologie obstétrique, hôpital Mahmoud El Martri Ariana.
La Tunisie Medicale
|February 26, 2010
Summary
Expectant management for premature rupture of membranes at term with an unfavorable cervix is safe. A 24-hour delay followed by labor induction, with prostaglandin E2 for cervical ripening, shows no increased maternal or neonatal morbidity.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Management of term premature rupture of membranes (PROM) remains controversial.
- Balancing expectant management with labor induction is a key clinical challenge.
Purpose of the Study:
- To evaluate the management of PROM at term in women with an unfavorable cervix.
- To assess the safety and efficacy of a structured management protocol.
Main Methods:
- Retrospective study of 137 patients with term PROM.
- Initial 24-hour expectant delay, followed by labor induction if needed.
- Cervical ripening with prostaglandins E2 (PGE2) for unfavorable cervices.
- Systematic antibiotic prophylaxis until delivery.
Main Results:
- 51% of patients initiated spontaneous labor during the expectant delay.
- No significant differences in neonatal or maternal morbidity were observed.
- The management protocol was associated with favorable outcomes.
Conclusions:
- A 24-hour expectant management period is a viable option for term PROM, even with unfavorable cervical conditions.
- Prostaglandin E2 maturation is a safe and effective method for cervical ripening in this population.
- This approach does not increase risks for mother or neonate.
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Uterus and Cervix
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

